Evidence map›Paper›PMID 30934947›Full record

ReviewMolecules (Basel, Switzerland)2019

Vera L Petricevich, Rodolfo Abarca-Vargas

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Anti-inflammatory & anti-allergy agents in medicinal chemistry · 2025
    Article
  4. Article
  5. Article
  6. The Meaning of Plants' Names: A New Discovering Approach to Its Medicinal and/or Toxic Properties.Evidence-based complementary and alternative medicine : eCAM · 2024
    Article
  7. Current drug discovery technologies · 2024
    Article
  8. Article
  9. Article
  10. A Plumieridine-Rich Fraction FromFrontiers in microbiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Vera L PetricevichFacultad de Medicina de la Universidad Autónoma del Estado de Morelos (UAEM), Calle, Leñeros, esquina Iztaccíhuatl s/n. Col. Volcanes, Cuernavaca, C.P. Morelos 62350, Mexico. vera.petricevich@uaem.mx.
Rodolfo Abarca-VargasFacultad de Medicina de la Universidad Autónoma del Estado de Morelos (UAEM), Calle, Leñeros, esquina Iztaccíhuatl s/n. Col. Volcanes, Cuernavaca, C.P. Morelos 62350, Mexico. rodolfo.abarca@uaem.mx.ORCID 0000-0002-9468-3484
Universidad Autónoma del Estado de Morelos · MX

Funding

Secretaría de Educación Pública ON.551-6/18-7513
6 · The paper itself

Abstract

In this work, we explore the current knowledge about the phytochemistry and in vitro and in vivo evaluations of the extracts and, where appropriate, the main active components characterized and isolated from the

Indexed as

ApocynaceaeBiotechnologyEthnopharmacologyMedicine, TraditionalMolecular StructurePhytochemicalsPlant ExtractsPlants, MedicinalToxicologyPhytochemicalsPlant ExtractsAllamanda catharticapharmacologyphytochemistrytoxicology and biotechnology

Identifiers

PMID30934947
PMCPMC6480200
OpenAlexW2924997622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.